🇺🇸 FDA
Patent

US 7951831

Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors

granted A61KA61K31/12A61K31/132

Quick answer

US patent 7951831 (Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors) held by The Regents of the University of California expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/12, A61K31/132, A61K31/167, A61K31/17